Author Archives

Recent Author Comments

On Microblog: Molecular Swiss Army Knife
Several modalities have been and continue to be tested to treat malignant gliomas [4–7], and gene therapy is undergoing extensive investigation [8–10] due to the widely characterized genetic defects of gliomas [1,11,12] and the delimited localization o[...]
On Microblog: terry84074
Is NDEV the right symbol or are you talking about something other than a pot stock? when I type NDEV in I get Novus Acquistion and Development Corporation[...]
On Ten Common Biotech Investing Mistakes
By the way, I do like your article about biotech rules.[...]
On Ten Common Biotech Investing Mistakes
So, do I hang on to TTOO since you recommended it a few days ago , or dump it and take my loss?[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch